We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

AI-Powered Algorithm Offers Quick, Contactless Blood Pressure and Diabetes Screening

By HospiMedica International staff writers
Posted on 13 Nov 2024

A newly developed system that combines high-speed video with an artificial intelligence (AI)-powered algorithm may provide a quick, non-contact method for screening high blood pressure and Type 1 or Type 2 diabetes, eliminating the need for blood tests, blood pressure cuffs, or costly wearable devices. More...

Although the system is still in the early stages of development, it could eventually offer rapid, contactless screenings for high blood pressure and diabetes, potentially aiding in the monitoring of treatment responses.

In the study, researchers at the University of Tokyo (Tokyo, Japan) evaluated the effectiveness of a high-speed video camera capable of capturing face and palm recordings at 150 images per second. By using wavelength data to detect pulse waves, the research team applied an AI algorithm to identify high blood pressure and diabetes through blood flow characteristics in the skin as captured by the video. When compared to continuous blood pressure monitor readings taken simultaneously with the video recordings, the video/algorithm combination demonstrated 94% accuracy in detecting stage 1 hypertension, as defined by the American Heart Association’s guidelines for blood pressure of 130/80 mm Hg or higher.

In comparison with continuous blood pressure monitor readings, the 30-second video/algorithm method showed 86% accuracy in detecting elevated blood pressure, while the 5-second video/algorithm method had 81% accuracy. Normal blood pressure readings were defined according to the Japanese Society of Hypertension guidelines (2018), which specify systolic pressure below 115 mm Hg and diastolic pressure below 75 mm Hg. When compared to hemoglobin A1c blood test results for diabetes screening, the video/algorithm system was 75% accurate in identifying individuals with diabetes. The A1c test measures average blood sugar levels over the previous 1-2 months. Although the technology shows promise, additional steps are needed before the video/algorithm combination can be applied outside of a research setting.

“To detect high blood pressure, we need to incorporate an algorithm that considers arrhythmias or irregular heartbeats,” said study author Ryoko Uchida, B.Sc. (Pharm.), a project researcher in the department of advanced cardiology at the University of Tokyo. “In the future, the prototype camera we used to develop the algorithm could be substituted with an affordable sensor that uses only the essential wavelengths and requires just a few seconds to gather data. Once it reaches that stage, it may be added to smartphones (or even hung on a mirror where someone sits for a few moments), may be mass-produced and inexpensive.”


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Pediatric Mask
Respire SOFT
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.